Lingnan Li

706 total citations
18 papers, 528 citations indexed

About

Lingnan Li is a scholar working on Molecular Biology, Immunology and Rheumatology. According to data from OpenAlex, Lingnan Li has authored 18 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Rheumatology. Recurrent topics in Lingnan Li's work include Psoriasis: Treatment and Pathogenesis (6 papers), Natural product bioactivities and synthesis (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Lingnan Li is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (6 papers), Natural product bioactivities and synthesis (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Lingnan Li collaborates with scholars based in China, United States and Austria. Lingnan Li's co-authors include Sreekumar Pillai, Peter Nash, Josef S Smolen, Soyi Liu Leage, Philip J. Mease, Hasan Tahir, Melinda Gooderham, Eswar Krishnan, Frank Behrens and Paul Emery and has published in prestigious journals such as PLoS ONE, Chemical Communications and Journal of Chromatography A.

In The Last Decade

Lingnan Li

17 papers receiving 518 citations

Peers

Lingnan Li

IMMUN

RHEUM

HEMAT

M. V. Gazzola Italy

Yaqiong Zhou China

Xueping Zhou China

Grégory Gatouillat France

Haixu Jiang China

Yuhun Lu United States

Yong‐Liang Chu China

Zeyad El-Akawi Jordan

Siddaraju M. Nanjundaiah United States

Chatri Ngamkitidechakul United States

M. V. Gazzola Italy

Lingnan Li

68 ×0.3

IMMUN

21 ×0.1

RHEUM

60 ×0.5

HEMAT

105 ×0.9

193 ×2.2

Citations per year, relative to Lingnan Li Lingnan Li (= 1×) peers M. V. Gazzola

Countries citing papers authored by Lingnan Li

Since Specialization

Citations

This map shows the geographic impact of Lingnan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingnan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingnan Li more than expected).

Fields of papers citing papers by Lingnan Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingnan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingnan Li. The network helps show where Lingnan Li may publish in the future.

Co-authorship network of co-authors of Lingnan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lingnan Li. A scholar is included among the top collaborators of Lingnan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingnan Li. Lingnan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Swanson, Chad J., Ferenc Martényi, Brian Campbell, et al.. (2024). Phase 1 Single and Multiple Dose Clinical Trials (ASCENT‐1 and ASCENT‐2) for Dose‐Finding of PRX012 in Participants with Biologically Confirmed Alzheimer’s Disease. Alzheimer s & Dementia. 20(S6).

Li, Lingnan, et al.. (2023). Dual-mode sensing of hydrogen peroxide on self-assembled Ag nanoparticles anchored on polydopamine wrapping 2D Cu-MOFs. Dalton Transactions. 52(29). 10231–10237. 7 indexed citations

Hebert, Adelaide A., Gaia Gallo, Lingnan Li, et al.. (2021). Higher rates of skin clearance and efficacy in challenging body areas are associated with better health‐related quality of life following ixekizumab maintenance treatment in pediatric patients with plaque psoriasis. Pediatric Dermatology. 39(1). 55–60. 5 indexed citations

Smolen, Josef S, Philip J. Mease, Hasan Tahir, et al.. (2020). Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52. Annals of the Rheumatic Diseases. 79(10). 1310–1319. 58 indexed citations

Luo, Jian‐Guang, Lingnan Li, Xiaoqin Liu, et al.. (2020). Precise separation of lysine-specific demethylase 1 inhibitors from Corydalis yanhusuo using multi-mode counter-current chromatography guided by virtual screening. Journal of Chromatography A. 1625. 461294–461294. 9 indexed citations

Smolen, Josef S, Anthony Sebba, Eric Ruderman, et al.. (2020). Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naïve Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study. Rheumatology and Therapy. 7(4). 1021–1035. 27 indexed citations

Smolen, Josef S, Peter Nash, Hasan Tahir, et al.. (2019). A Head-to-Head Comparison of Ixekizumab and Adalimumab in Biologic-Naive Patients with Active Psoriatic Arthritis: Efficacy and Safety Outcomes from a Randomized, Open-Label, Blinded Assessor Study Through 52 Weeks. Queensland's institutional digital repository (The University of Queensland). 71. 5266–5267. 1 indexed citations

Mease, Philip J., Josef S Smolen, Frank Behrens, et al.. (2019). A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Annals of the Rheumatic Diseases. 79(1). 123–131. 208 indexed citations

Han, Chao, Wenli Wang, Lingnan Li, et al.. (2019). Integrative countercurrent chromatography for the target isolation of lysine-specific demethylase 1 inhibitors from the roots of Salvia miltiorrhiza. Talanta. 206. 120195–120195. 18 indexed citations

10.

Mease, Philip J., Josef S Smolen, Frank Behrens, et al.. (2019). LB0005 MULTICENTRE, RANDOMISED, OPEN-LABEL, ASSESSOR-BLINDED, PARALLEL-GROUP HEAD-TO-HEAD COMPARISON OF THE EFFICACY AND SAFETY OF IXEKIZUMAB VERSUS ADALIMUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS NAIVE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: 24-WEEK RESULTS. Annals of the Rheumatic Diseases. 78. 261–262. 6 indexed citations

11.

Zhu, Tianyu, Chen Chen, Sisi Wang, et al.. (2019). Cellular target identification of Withangulatin A using fluorescent analogues and subsequent chemical proteomics. Chemical Communications. 55(57). 8231–8234. 9 indexed citations

12.

Li, Lingnan, Tianyu Zhu, Gui‐Min Xue, et al.. (2019). Anti-inflammatory norabietane diterpenoids from the leaves of Salvia officinalis L.. Journal of Functional Foods. 54. 154–163. 24 indexed citations

13.

Liang, Xiaofei, Bo Wang, Lingnan Li, et al.. (2018). Pathogenic adaptations of Colletotrichum fungi revealed by genome wide gene family evolutionary analyses. PLoS ONE. 13(4). e0196303–e0196303. 54 indexed citations

14.

Li, Lingnan, Miaomiao Zhou, Gui‐Min Xue, et al.. (2018). Bioactive seco-abietane rearranged diterpenoids from the aerial parts of Salvia prionitis. Bioorganic Chemistry. 81. 454–460. 23 indexed citations

15.

Li, Lingnan, et al.. (2017). Effects of Gnaphalium affine D. Don on hyperuricemia and acute gouty arthritis. Journal of Ethnopharmacology. 203. 304–311. 32 indexed citations

16.

Tan, Dehong, Lingnan Li, Sha Wang, et al.. (2013). The cytogenetic effects of acrylamide on Carassius auratus periperial blood cells. Food and Chemical Toxicology. 62. 318–322. 13 indexed citations

17.

Li, Lingnan, Yi Yang, Xueling Hou, et al.. (2012). Bioassay-guided separation and purification of water-soluble antioxidants from Carthamus tinctorius L. by combination of chromatographic techniques. Separation and Purification Technology. 104. 200–207. 31 indexed citations

18.

Lei, Weimin, et al.. (2009). The Implementation of Fast Channel Switching in IPTV. 684–688. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact